Cholesterol is essential for cell function, but its balance hinges on hepatic LDL receptor (LDLR) abundance, which dictates how efficiently the liver clears circulating lipoproteins. Researchers at the University of California, San Diego (UCSD) identified a Ral-dependent pathway by which elevated cholesterol intake reduces hepatic LDLR availability, pointing to a potential target for lipid-lowering therapies.